Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Comment
. 2021 Dec;43(1):1463-1464.
doi: 10.1080/0886022X.2021.1994419.

ACE-inhibitor/angiotensin receptor blockers (ACE-I/ARBs) therapy in COVID-19 infected dialysis patients

Ahmed Daoud  1 , Hatem Ali  2 , Vinaya Rao  3 , Vinayak Rohan  4 , Karim Soliman  3
Affiliations
Comment

ACE-inhibitor/angiotensin receptor blockers (ACE-I/ARBs) therapy in COVID-19 infected dialysis patients

Ahmed Daoud et al. Ren Fail. 2021 Dec.
No abstract available

PubMed Disclaimer

Conflict of interest statement

No potential conflict of interest was reported by the author(s). Drs. Rao and Soliman are members of the editorial board of Renal Failure.

Figures

Figure 1.
Figure 1.
Relationship between ACE-I/ARBs therapy and mortality in COVID-19 infected dialysis patients.
See this image and copyright information in PMC

Comment on

References

    1. Bian J, Li Z.. Angiotensin-converting enzyme 2 (ACE2): SARS-CoV-2 receptor and RAS modulator. Acta Pharm Sin B. 2021;11(1):1–12. - PMC - PubMed
    1. Jarcho JA, Ingelfinger JR, Hamel MB, et al. . Inhibitors of the renin-angiotensin-aldosterone system and covid-19. N Engl J Med. 2020;382(25):2462–2464. - PMC - PubMed
    1. Zhang P, Zhu L, Cai J, et al. . Association of inpatient use of angiotensin-converting enzyme inhibitors and angiotensin II receptor blockers with mortality among patients with hypertension hospitalized with COVID-19. Circ Res. 2020;126(12):1671–1681. - PMC - PubMed
    1. Hsu CM, Weiner DE, Aweh G, et al. . COVID-19 among US dialysis patients: risk factors and outcomes from a national dialysis provider. Am J Kidney Dis. 2021;77(5):748–756.e1. - PMC - PubMed
    1. Sánchez-Alvarez E, Macía M, de Sequera Ortiz P.. Management of hemodialysis patients with suspected or confirmed COVID-19 infection: perspective from the Spanish nephrology. Kidney360. 2020;1(11):1254–1258. - PMC - PubMed

MeSH terms

Substances